Skip to main content

CABOT CORP

corporate_fare Company Profile

CABOT CORP

CBT·NYSE·Basic Materials·CIK 0000016040

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company, founded in 1882 and incorporated in Delaware in 1960, manufactures principal products including reinforcing and specialty carbons, specialty compounds, conductive additives, carbon nanotubes, fumed metal oxides, inkjet colorants, and aerogel. Cabot and its affiliates operate manufacturing facilities and operations in the United States and over 20 other countries. The company's products are based on technical expertise and innovation in four core competencies: making and handling very fine particles; modifying the surfaces of very fine particles to alter their functionality; designing particles to impart specific properties to a formulation; and combining particles with other ingredients to deliver a formulated performance intermediate or composite. Cabot focuses on creating particles and formulations with specific composition, morphology, and surface functionalities to support customer applications. The business is organized into two reportable segments: Reinforcement Materials and Performance Chemicals.

CABOT CORP (NYSE:CBT) is a publicly traded company in the Basic Materials sector. Wiseek monitors CBT SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Cabot Secures New $1.3 Billion Unsecured Revolving Credit Facility, Extending Maturity to 2031
  • Cabot Reports Q2 GAAP EPS Decline, Announces $79M Restructuring & Plant Closures
  • Cabot Reports Q2 Adjusted EPS of $1.61, Announces Plant Closures for $22M Annual Savings
  • Cabot Exceeds Q2 EPS Estimates by 10%, Provides Strong FY Outlook
  • Cabot Boosts Quarterly Dividend by 5% to 47.25 Cents, Signaling Confidence

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$3.71B
Net Income
$331M
Diluted EPS
$6.02
Op. Cash Flow
$665M
Free Cash Flow
$391M
Gross Profit
$940M
Operating Income
$621M
Cash & Equivalents
$258M
Total Debt
$1.12B
Debt / Equity
0.72×
Net Margin
8.9%
Shares Outstanding
52.84M sh
Source: 10-K · filed 2025-11-24 · accession 0001193125-25-292412
Browse all tickers starting with C →
$87.6 -0.05% today
52-week range · as of 2026-05-14 $58.33 – $86.43
Market cap
$4.52B
Volume
463.3K (1.0× avg)
3-mo avg 482.8K
Live data · 2026-06-14 03:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CBT - Latest Insights

CBT
May 14, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $82.90
Real-time Price: $87.60 info
Change: +$4.70 (+6%) info
Market Cap: $4.525B info
CBT
May 06, 2026, 4:23 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $82.41
Real-time Price: $87.60 info
Change: +$5.19 (+6%) info
Market Cap: $4.525B info
CBT
May 05, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.66
Real-time Price: $87.60 info
Change: +$7.94 (+10%) info
Market Cap: $4.525B info
CBT
May 05, 2026, 4:30 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $78.93
Real-time Price: $87.60 info
Change: +$8.67 (+11%) info
Market Cap: $4.525B info
CBT
May 04, 2026, 7:16 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $75.85
Real-time Price: $87.60 info
Change: +$11.75 (+15%) info
Market Cap: $4.525B info
CBT
Feb 04, 2026, 1:36 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $78.93
Real-time Price: $87.60 info
Change: +$8.67 (+11%) info
Market Cap: $4.525B info
CBT
Feb 03, 2026, 4:40 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $71.20
Real-time Price: $87.60 info
Change: +$16.40 (+23%) info
Market Cap: $4.525B info